Navigation Links
Argentum Medical Issues Response to Recent Decision in Litigation With Noble Biomaterials
Date:3/14/2011

CHICAGO, March 14, 2011 /PRNewswire/ -- Argentum Medical, LLC today issued a response to the recent decision in their patent infringement litigation versus Noble Biomaterials, Inc.

"The most important thing to know is the trial has no impact on our patents and it is business as usual for Argentum," said Gregg Silver, Chairman and CEO of Argentum Medical, LLC. "The case concerned non-patent issues and is currently being appealed. We are confident that our appeal will be successful."

Argentum Medical is an industry leader in antimicrobial silver dressings. The company manufactures more than 60 different combinations and sizes of Silverlon® products, and has developed 14 unique categories of wound, burn and post-surgical dressings. Argentum has sold more than three million dressings to more than 2,000 customers, including the Mayo Clinic, Johns Hopkins University, University of Michigan and the Department of Defense.

This month marks Argentum Medical's 10th anniversary. The company has experienced record sales in 2010, with the Silverlon Surgical Wound Pad and Island Dressings achieving domestic sales growth of more than 300% in the second half of the year.

Silver adds, "The litigation will not affect our customers. We will continue to provide our customers with Silverlon® and our other leading products. We are a financially strong company, and service to our customers will not be affected by any expenses resulting from this lawsuit."

Argentum prides itself on groundbreaking innovation, and has particular success with its Silverlon® Negative Pressure Dressing (NPD), which was named Innovative Product of the Year by Frost and Sullivan in 2006. NPD continues to be one of the company's fastest growing categories today. It was the first antimicrobial silver dressing designed to be utilized with negative pressure wound therapy.

About Argentum Medical

Headquartered in Chicago, Illinois, Argentum Medic
'/>"/>

SOURCE Argentum Medical, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. D3 Oncology Solutions Now Includes Via Oncology Pathways for Medical Oncology
2. WARFARIN Study Launched at Overlake Hospital Medical Center to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
3. Sensus Healthcare Announces the Formation of a Medical Advisory Board
4. Chimerix Awarded BARDA Contract for Advanced Development of Broad Spectrum Antiviral CMX001 as Medical Countermeasure Against Smallpox
5. Aethlon Medical to Present at the Wall Street Analyst Forum 22nd Annual Investor Conference
6. Cantel Medical Acquires the Sterilization Monitoring Business of ConFirm Monitoring Systems, Inc.
7. Larta Institute NIH Success Stories Featured in 2011 California Biomedical Industry Report
8. DiaTech Oncology and Walter Reed Army Medical Center Establish Pilot to Determine Best Chemotherapy for Cancer Patients
9. Gizmox Enters the Business Mobile Application Market - Visual WebGui Based Solutions Deployed in Major Financial and Medical Institutions
10. Californias Biomedical Industry is Poised for Growth Despite Increasing Global Competition, According to the 2011 California Biomedical Industry Report
11. Ingenuity Systems and Erasmus University Medical Center Collaborate on Next-Generation Sequencing Project to Accelerate Disease Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Washington, USA (PRWEB) September 30, 2014 ... yet efficient arrangements that have evolved in nature over ... biomimetic and bioinspired materials for applications in biophotonics ... Biomedical Optics . The journal is published by SPIE, ... SPIE Digital Library. Several of the peer-reviewed articles are ...
(Date:10/1/2014)... 2014 TeselaGen Biotechnology has ... to expand their bioCAD/CAM software suite, which uses ... The Small Business Innovation Research Phase II grant will ... exclusive license from the Lawrence Berkeley National Laboratory. j5 ... an LBNL laboratory that develops alternative fuel technologies for ...
(Date:10/1/2014)... 1, 2014 Industry leaders ... to engage around the theme, ,Commercial Opportunities in the ...   Elsevier , a world-leading provider ... will host a gathering of some of the industry,s ... impacting healthcare today and in the future. The ...
(Date:9/30/2014)... in German . ... (TUM) have demonstrated a new kind of building block ... computer chips could be based on three-dimensional arrangements of ... technology of the semiconductor industry CMOS fabrication of ... and collaborators at the University of Notre Dame are ...
Breaking Biology Technology:Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 2Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 3TeselaGen Receives $750k NSF SBIR Phase II Award 2TeselaGen Receives $750k NSF SBIR Phase II Award 3Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3A new dimension for integrated circuits: 3-D nanomagnetic logic 2A new dimension for integrated circuits: 3-D nanomagnetic logic 3
... CITY, China , May 11 /PRNewswire-Asia-FirstCall/ -- China Pharma,Holdings, ... leading,fully-integrated specialty pharmaceuticals company in China , today announced,financial results for ... First Quarter Highlights, -- Revenue increased 16% ... quarter of fiscal 2009, -- Gross ...
... of Gothenburg, Sweden, have managed, with the help of an ... photosynthesis an achievement that has been recognised by the ... Facility in Grenoble is home to one of the world,s ... by researchers to photograph and study life,s tiniest components: atoms, ...
... , May 10 BioMed Realty Trust, Inc. (NYSE: ... be held on Tuesday, May 11, 2010 at BioMed,s The Landmark ... feature presentations by Alan D. Gold , Chairman and Chief Executive Officer, ... , , ...
Cached Biology Technology:China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 2China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 3China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 4China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 5China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 6China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 7China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 8China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 9China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 10China Pharma Holdings, Inc. Reports First Quarter 2010 Financial Results 11BioMed Realty Trust to Webcast Company Presentation at Investor Day 2010 2
(Date:9/30/2014)... as something that we enjoy when we visit a national ... think of ourselves as a part of nature? A bird,s ... house? , The answers to these questions reflect different ... speech and in cultural artifacts. , A new Northwestern University ... Indian Center of Chicago and the Menominee tribe of Wisconsin, ...
(Date:9/30/2014)... The National Institutes of Health (NIH) awarded ... to develop an electrode array system that will ... works through unprecedented resolution and scale. , LLNL,s ... support President Obama,s BRAIN (Brain Research through ... effort to revolutionize our understanding of the human ...
(Date:9/30/2014)... Journal of Medicine reports positive results of a ... the subset of lung cancer marked by rearrangement of ... patients with advanced non-small cell lung cancer testing positive ... percent, with 3 complete responses and 33 partial responses. ... the disease to resume its growth after being slowed ...
Breaking Biology News(10 mins):The cultural side of science communication 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 3NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2
... changes in the earth,s atmospheric composition are likely to ... dioxide will reach levels double those of the preindustrial ... produce enough food for a rapidly growing population. ... of elevated carbon dioxide, elevated ozone and higher atmospheric ...
... This release is available in German . ... so far considered antagonists, also work synergistically. The activities of ... formation of organs, such as leaves and buds, are in ... Tbingen (Germany) and Umea (Sweden) made this surprising discovery in ...
... AUGUSTA, Ga. - The most common and under-diagnosed ... the worst form of macular degeneration, Medical College of Georgia ... which results in iron overload, and the wet form of ... and older. They suspect that too much iron, known to ...
Cached Biology News:Climate change complicates plant diseases of the future 2Climate change complicates plant diseases of the future 3Plant growth hormones: Antagonists cooperate 2Link between iron overload and macular degeneration under study 2Link between iron overload and macular degeneration under study 3
Request Info...
Recombinant Rat Leptin, Ultra Pure...
Lentigen's manufacturing platform is sufficiently versatile for use in the manufacture of any HIV-based Lentiviral vector. Lentigen will manufacture your LV of choice to the highest possible titer a...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: